Cubist Systematic Strategies’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
DCM
MP
BC
GCP
CB
Cubist Systematic Strategies's TCRT Position: Q3 2023 in Review
Cubist Systematic Strategies sold out of Alaunos Therapeutics (TCRT) in Q3 2023, closing a stake of 275 shares — an estimated $21K sold.
Cubist Systematic Strategies first reported a position in TCRT in Q1 2015 and held it in 17 quarters. The position peaked at $602K in Q3 2022. 89 funds tracked by Wall St. Rank hold TCRT as of Q3 2023.
- Cubist Systematic Strategies reported no remaining Alaunos Therapeutics position as of Q3 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 275 Alaunos Therapeutics shares in Q3 2023, an estimated $21K.
- Cubist Systematic Strategies first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 17 quarters.
- Cubist Systematic Strategies's Alaunos Therapeutics position peaked at $602K in Q3 2022.
- 89 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2023.
Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.